August 16, 2016 — With over 7,000 Xarelto lawsuits now filed, a federal judge in Louisiana has picked two cases for the first “bellwether” trials scheduled for February 2017.
U.S. District Judge Eldon Fallon picked a case involving a man from Louisiana who experienced gastrointestinal bleeding after taking Xarelto for the first trial, according to Reuters.
The second trial will involve a person who experienced brain bleeding or a hemorrhagic stroke after taking Xarelto.
Judge Fallon has not yet chosen the remaining lawsuits to go to trial, but the third case will involve a person who experienced gastrointestinal bleeding after taking Xarelto to treat Deep Vein Thrombosis (DVT) or a Pulmonary Embolism (PE).
The lawsuits are centralized in a federal Multi-District Litigation (MDL No. 2592) in the Eastern District of Louisiana.
Xarelto was released in 2011 as an alternative to warfarin, which has been the top anti-clotting medication for the past 60 years. Unlike warfarin, Xarelto lacks a reversal agent and is not easily de-activated when a patient starts bleeding.
All of the lawsuits accuse Bayer and Janssen Pharmaceuticals of downplaying the risk of severe, uncontrollable bleeding from Xarelto to promote it as superior to warfarin.
Need a Xarelto Lawyer in Texas?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Xarelto lawyers for a free lawsuit review.